May 7 |
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
|
May 6 |
Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back
|
May 4 |
23 Most Profitable Stocks of the Last 12 Months
|
May 3 |
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
|
May 3 |
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
|
May 2 |
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
|
May 1 |
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
|
Apr 30 |
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
|
Apr 29 |
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
|
Apr 29 |
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
|